Quantum-Si Incorporated (QSI) EV/EBITDA Multiple

Quantum-Si (QSI) develops protein analysis chips, generating revenue through the sale of desktop systems to laboratories and institutes. This chart of the company's price action with the 0.00 metric highlights scaling potential driven by fixed design costs and outsourced manufacturing. The business is currently focused on bringing products to market via applied research with scientific centers without engaging in M&A transactions.

QSI (Quantum-Si Corp) Business Value to Operating Income Before Depreciation history from 11/23/2025 to 11/10/2026

QSI (quantum-si.com): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price Quantum-Si Corp|QSI - Analyst Median Target

- market capitalization details:

Market Capitalization Quantum-Si Corporation|QSI - Real Price to Acquire Entire Company

- issuer book value statistics:

Accounting Value per Share Quantum-Si|QSI - Accounting Value of Company|Market Value to Book Value Ratio quantum-si.com|QSI - Cumulative Company Assets

- debt level and financial liquidity data:

- net income and valuation multiples indicators:

QSI - Net Profit|Expected Profit Quantum-Si|QSI - Price to Earnings Ratio|Projected Price to Earnings Quantum-Si|QSI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Quantum-Si Corporation|QSI - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Quantum-Si|QSI - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months quantum-si.com|QSI - Earnings growth in current year|Earnings growth forecast for next year Quantum-Si

Fundamental company valuation:Quantum-Si Corp QSI

The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit before interest, taxes, depreciation, and amortization to determine the actual value of assets. A decrease in this ratio signals undervaluation, although an excessive decline may indicate falling liquidity. By analyzing EV/EBITDA dynamics, an investor assesses capitalization rates. For Quantum-Si (QSI), this indicator reflects the efficiency of the commercial rollout of the Platinum platform within the proteomics sector.

Analysis of competing companies

EV/EBITDA Multiple ABT (Abbott Laboratories Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Thermo Scientific (TMO)|GE HealthCare - EV/EBITDA Multiple|mt.com (MTD) - Enterprise Value to EBITDA Ratio|WAT (Waters) - Enterprise Value to EBITDA Ratio|Bio-Techne Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bruker Corp.|Enterprise Value to EBITDA Ratio Brooks Automation (AZTA)|EV/EBITDA Multiple VREX|SMLR - Company Value to EBITDA|EV/EBITDA Multiple BFLY (Butterfly Network)|MLAB: Enterprise Value to Operating Income Before Depreciation|Nanox - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Quanterix Inc QTRX|MASS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio CapsoVision|MXCT (MaxCyte) - EV/EBITDA Multiple|EV/EBITDA Multiple Rapid Micro|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Seer Inc. (SEER)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HYPR (Hyperfine Medical)|FONAR Corporation - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DXR|Spectral AI, Inc. - EV/EBITDA Multiple|Company Value to EBITDA Organovo Holdings|Aclarion Corp (ACON) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Multiple Akoya Biosciences, Inc. AKYA|Enterprise Value to EBITDA Ratio THMO|EV/EBITDA Multiple Talis Biomedical Corp|EV/EBITDA Multiple TTOO